| scholarly article | Q13442814 |
| P2093 | author name string | Fournier A | |
| Vaudry H | |||
| Vaudry D | |||
| Gonzalez BJ | |||
| Basille M | |||
| P2860 | cites work | Differential signal transduction by five splice variants of the PACAP receptor | Q28566746 |
| The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide | Q28571396 | ||
| Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide | Q28578845 | ||
| Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. | Q36684306 | ||
| Somatostatin receptors are expressed by immature cerebellar granule cells: evidence for a direct inhibitory effect of somatostatin on neuroblast activity | Q37246839 | ||
| The regulation and function of c-fos and other immediate early genes in the nervous system | Q37583743 | ||
| Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells | Q38289335 | ||
| Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction | Q40537986 | ||
| Type I receptors for PACAP (a neuropeptide even more important than VIP?). | Q40770467 | ||
| PACAP stimulates transcription of c-Fos and c-Jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells | Q41206532 | ||
| C-terminal substance P fragments elicit histamine release from a murine mast cell line | Q41588136 | ||
| Mitogenic and antimitogenic effects of pituitary adenylate cyclase-activating polypeptide (PACAP) in adult rat chromaffin cell cultures | Q41677543 | ||
| Pituitary adenylate cyclase-activating polypeptide activates different signal transducing mechanisms in cultured cerebellar granule cells | Q42486733 | ||
| Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) and its binding sites in the rat brain | Q48154706 | ||
| Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain | Q48224950 | ||
| Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. | Q48387554 | ||
| Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections | Q48508938 | ||
| Distribution of enkephalin immunoreactivity in germinative cells of developing rat cerebellum | Q48515981 | ||
| The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain | Q48560539 | ||
| Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary | Q48620158 | ||
| Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord | Q48673193 | ||
| Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). | Q48931112 | ||
| Developmental changes in bombesin, substance P, somatostatin and vasoactive intestinal polypeptide in the rat brain | Q49017321 | ||
| High affinity block by nimodipine of the internal calcium elevation in chronically depolarized rat cerebellar granule neurons. | Q49049889 | ||
| The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. | Q51789112 | ||
| DNA fragmentation and activation of c-Jun in the cerebellum of mutant mice (weaver, Purkinje cell degeneration). | Q52205994 | ||
| Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactive neuronal elements in rat hypothalamus and median eminence with special reference to morphological background of its effect on anterior pituitary--light and electron micro | Q53860329 | ||
| Phenotypic development of neonatal rat chromaffin cells in response to adrenal growth factors and glucocorticoids: focus on pituitary adenylate cyclase activating polypeptide | Q57206899 | ||
| 38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells. | Q64957657 | ||
| Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells | Q69772725 | ||
| PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta | Q71337066 | ||
| Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells | Q71530679 | ||
| c-fos Expression in the rat brain after unilateral labyrinthectomy and its relation to the uncompensated and compensated stages | Q71631081 | ||
| Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis | Q71675839 | ||
| Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) Stimulates Adenylyl Cyclase and Phospholipase C Activity in Rat Cerebellar Neuroblasts | Q71978497 | ||
| Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells | Q72259525 | ||
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide potentiate c-fos expression induced by glutamate in cultured cortical neurons | Q72334782 | ||
| Localization of pituitary adenylate cyclase-activating polypeptide (PACAP) in the hypothalamus-pituitary system in rats: light and electron microscopic immunocytochemical studies | Q72423976 | ||
| Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the rat cerebellum: a quantitative autoradiographic study | Q72503954 | ||
| Pituitary adenylate cyclase activating peptide and vasoactive intestinal polypeptide: differentiation effects on human neuroblastoma NB-OK-1 cells | Q72661015 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurite | Q1534415 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 419-430 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts | |
| P478 | volume | 78 |
| Q89081314 | A Peptidomic Approach to Characterize Peptides Involved in Cerebellar Cortex Development Leads to the Identification of the Neurotrophic Effects of Nociceptin |
| Q36832414 | Activation of PAC1 Receptors in Rat Cerebellar Granule Cells Stimulates Both Calcium Mobilization from Intracellular Stores and Calcium Influx through N-Type Calcium Channels |
| Q43850091 | Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides |
| Q34293821 | Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). |
| Q48763774 | Biochemical characterization of a Caspase-3 far-red fluorescent probe for non-invasive optical imaging of neuronal apoptosis. |
| Q34445988 | Caught in the matrix: how vitronectin controls neuronal differentiation |
| Q35948321 | Cerebellar cortical-layer-specific control of neuronal migration by pituitary adenylate cyclase-activating polypeptide. |
| Q61774069 | Chapter II Brain PACAP/VIP receptors: regional distribution, functional properties and physiological relevance |
| Q48140323 | Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda |
| Q33624771 | Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies |
| Q28578421 | Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior |
| Q36211439 | Class II G protein-coupled receptors and their ligands in neuronal function and protection |
| Q28586621 | Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog |
| Q44568466 | Cortical-layer-specific effects of PACAP and tPA on interneuron migration during post-natal development of the cerebellum |
| Q38322070 | Delineating the factors and cellular mechanisms involved in the survival of cerebellar granule neurons. |
| Q44250352 | Developmental changes in the expression of growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in zebrafish |
| Q52169880 | Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system. |
| Q44376581 | Direct cAMP signaling through G-protein-coupled receptors mediates growth cone attraction induced by pituitary adenylate cyclase-activating polypeptide. |
| Q43939760 | Distribution and molecular evolution of the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the lizard Podarcis sicula (Squamata, Lacertidae). |
| Q44999450 | Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain |
| Q39672838 | Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. |
| Q43824634 | Embryonic expression of pituitary adenylyl cyclase-activating polypeptide and its selective type I receptor gene in the frog Xenopus laevis neural tube |
| Q34280402 | Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult |
| Q37599989 | Engrailed2 modulates cerebellar granule neuron precursor proliferation, differentiation and insulin-like growth factor 1 signaling during postnatal development |
| Q28509469 | Expression of PACAP, and PACAP type 1 (PAC1) receptor mRNA during development of the mouse embryo |
| Q43764459 | Expression of pituitary adenylate cyclase-activating polypeptide mRNA in the cochlea of rats |
| Q43916537 | Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition |
| Q36105469 | G-protein-coupled receptors in adult neurogenesis |
| Q46647393 | Granule cell survival is deficient in PAC1-/- mutant cerebellum. |
| Q74529093 | Increased expression, axonal transport and release of pituitary adenylate cyclase-activating polypeptide in the cultured rat vagus nerve |
| Q64354619 | Induction of Neuronal Differentiation of Murine N2a Cells by Two Polyphenols Present in the Mediterranean Diet Mimicking Neurotrophins Activities: Resveratrol and Apigenin |
| Q34254935 | Induction of serpinb1a by PACAP or NGF is required for PC12 cells survival after serum withdrawal |
| Q37174527 | Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. |
| Q37198666 | Interactions of PACAP and ceramides in the control of granule cell apoptosis during cerebellar development |
| Q41822449 | Light-Triggerable Liposomes for Enhanced Endolysosomal Escape and Gene Silencing in PC12 Cells |
| Q28304461 | Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development |
| Q41900340 | Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation |
| Q31885090 | Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons |
| Q42611831 | Molecular cloning and expression of a chicken pituitary adenylate cyclase-activating polypeptide receptor |
| Q48090932 | Molecular, cellular, and functional characterizations of pituitary adenylate cyclase-activating polypeptide and its receptors in the cerebellum of New and Old World monkeys |
| Q44044533 | Mouse pituitary adenylate cyclase-activating polypeptide (PACAP): gene, expression and novel splicing |
| Q40595641 | Neuritogenesis induced by vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and peptide histidine methionine in SH-SY5y cells is associated with regulated expression of cytoskeleton mRNAs and proteins |
| Q48222782 | Neuroprotective effects of PACAP against ethanol-induced toxicity in the developing rat cerebellum. |
| Q34179881 | Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases |
| Q35606272 | Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development |
| Q31912005 | Ontogeny of pituitary adenylate cyclase-activating polypeptide (PACAP) in the frog (Rana ridibunda) tadpole brain: immunohistochemical localization and biochemical characterization. |
| Q44215032 | PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells |
| Q50701918 | PAC1-expressing structures of neural retina alter their PAC1 isoform splicing during postnatal development. |
| Q28834687 | PAC1R agonist maxadilan enhances hADSC viability and neural differentiation potential |
| Q39202876 | PACAP Protects the Adolescent and Adult Mice Brain from Ethanol Toxicity and Modulates Distinct Sets of Genes Regulating Similar Networks |
| Q35586514 | PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF. |
| Q44831617 | PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of I k in the anti-apoptotic action of PACAP. |
| Q34291476 | PACAP is present in the olfactory system and evokes calcium transients in olfactory receptor neurons |
| Q44004718 | PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis |
| Q41941323 | PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases |
| Q43584809 | Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons. |
| Q47930618 | Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland |
| Q36153216 | Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. |
| Q34484172 | Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation |
| Q43073178 | Pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neural progenitor cell survival, proliferation, and differentiation |
| Q45871638 | Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP. |
| Q28115858 | Pituitary adenylate cyclase-activating polypeptide 38-mediated Rin activation requires Src and contributes to the regulation of HSP27 signaling during neuronal differentiation |
| Q34310714 | Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians. |
| Q28507296 | Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation |
| Q46399968 | Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system. |
| Q33850713 | Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling |
| Q34029443 | Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death |
| Q48473899 | Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway |
| Q44401713 | Pituitary adenylate cyclase‐activating polypeptide prevents C2‐ceramide‐induced apoptosis of cerebellar granule cells |
| Q43888083 | Pituitary adenylyl cyclase-activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase |
| Q36592081 | Ring chromosome 18 in combination with 18q12.1 (DTNA) interstitial microdeletion in a patient with multiple congenital defects. |
| Q32031709 | Role of PAC(1) receptor in adrenal catecholamine secretion induced by PACAP and VIP in vivo |
| Q37019460 | Role of PACAP in the physiology and pathology of the sympathoadrenal system. |
| Q35667237 | STC1 induction by PACAP is mediated through cAMP and ERK1/2 but not PKA in cultured cortical neurons |
| Q46628267 | Signaling cascades involved in neuroprotection by subpicomolar pituitary adenylate cyclase-activating polypeptide 38. |
| Q28513370 | Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells |
| Q73798316 | Structure and distribution of the mRNAs encoding pituitary adenylate cyclase-activating polypeptide and growth hormone-releasing hormone-like peptide in the frog, Rana ridibunda |
| Q36787413 | The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. |
| Q37296125 | The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32 |
| Q48295236 | The neurotrophic activity of PACAP on rat cerebellar granule cells is associated with activation of the protein kinase A pathway and c-fos gene expression |
| Q48297819 | The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells |
| Q27028148 | The role of soluble adenylyl cyclase in neurite outgrowth |
Search more.